NICHOL GEOFFREY 4/A
4/A · Tempest Therapeutics, Inc. · Filed Sep 20, 2021
Insider Transaction Report
Form 4/AAmended
NICHOL GEOFFREY
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-01+6,635→ 6,635 totalExercise: $11.07Exp: 2031-06-30→ Common Stock (6,635 underlying)
Footnotes (1)
- [F1]Vests over three (3) years, with one-third (1/3) of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.